GB9918180D0 - Novel compositions - Google Patents
Novel compositionsInfo
- Publication number
- GB9918180D0 GB9918180D0 GBGB9918180.2A GB9918180A GB9918180D0 GB 9918180 D0 GB9918180 D0 GB 9918180D0 GB 9918180 A GB9918180 A GB 9918180A GB 9918180 D0 GB9918180 D0 GB 9918180D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compositions
- compositions
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9918180.2A GB9918180D0 (en) | 1999-08-02 | 1999-08-02 | Novel compositions |
JP2001514309A JP2003506362A (ja) | 1999-08-02 | 2000-07-31 | Gsk−3阻害剤としてのジアミノ−1,2,4−トリアゾール−カルボン酸誘導体 |
EP00958343A EP1200415A1 (fr) | 1999-08-02 | 2000-07-31 | Composes diamino-1,2,4-triazole-acide carboxylique et derives de ces derniers utiles en tant qu'inhibiteurs de gsk-3 |
PCT/EP2000/007423 WO2001009106A1 (fr) | 1999-08-02 | 2000-07-31 | Composes diamino-1,2,4-triazole-acide carboxylique et derives de ces derniers utiles en tant qu'inhibiteurs de gsk-3 |
AU69898/00A AU6989800A (en) | 1999-08-02 | 2000-07-31 | Diamino-1,2,4-triazole-carboxylic and derivatives as gsk-3 inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9918180.2A GB9918180D0 (en) | 1999-08-02 | 1999-08-02 | Novel compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9918180D0 true GB9918180D0 (en) | 1999-10-06 |
Family
ID=10858425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9918180.2A Ceased GB9918180D0 (en) | 1999-08-02 | 1999-08-02 | Novel compositions |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1200415A1 (fr) |
JP (1) | JP2003506362A (fr) |
AU (1) | AU6989800A (fr) |
GB (1) | GB9918180D0 (fr) |
WO (1) | WO2001009106A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1286964B1 (fr) | 2000-05-11 | 2007-07-04 | Consejo Superior de Investigaciones Cientificas | Inhibiteurs heterocycliques de la glycogene synthase kinase gsk-3 |
ES2166328B1 (es) * | 2000-05-11 | 2003-09-16 | Consejo Superior Investigacion | Inhibidores heterociclicos del enzima gsk 3 utiles en el tratamiento de procesos neurodegenerativos e hiperproliferativos |
PT1355889E (pt) * | 2000-12-22 | 2006-09-29 | Ortho Mcneil Pharm Inc | Derivados diamina triazole substituidos como inibidores de cinase |
EP1712550A3 (fr) * | 2000-12-22 | 2009-07-15 | Ortho-McNeil Pharmaceutical, Inc. | Dérivés de triazole diamine substitués comme inhibiteurs de kinases |
GB0103031D0 (en) * | 2001-02-07 | 2001-03-21 | Smithkline Beecham Plc | Novel treatment |
EP1417188A1 (fr) * | 2001-08-03 | 2004-05-12 | Novo Nordisk A/S | Nouveaux derives de la 2,4-diaminothiazole |
TW201041580A (en) * | 2001-09-27 | 2010-12-01 | Alcon Inc | Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
CA2581126A1 (fr) | 2004-09-24 | 2006-04-06 | Rfe Pharma Llc | Systemes bases sur cai et methodes de traitement localise de maladies oculaires et autres |
US20160106717A1 (en) | 2004-09-24 | 2016-04-21 | Gen Pharma Holdings LLC | Cai-based systems and methods for the localized treatment of uveitis |
BRPI0516569A (pt) | 2004-10-08 | 2008-09-16 | Janssen Pharmaceutica Nv | derivados de 1,2,4-triazolilaminoaril(heteroaril)sulfonamida |
EP2258358A3 (fr) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenèse avec un inhibiteur de l'acetylcholinestérase |
EP2275095A3 (fr) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenese par modulation des recepteurs muscariniques |
EP1922310A2 (fr) | 2005-09-07 | 2008-05-21 | Rigel Pharmaceuticals, Inc. | Derives de triazole utiles comme inhibiteurs d'axl |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
CA2625210A1 (fr) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Modulation de la neurogenese dont la mediation est assuree par recepteur gaba |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
EP2114954B1 (fr) | 2006-12-29 | 2013-02-13 | Rigel Pharmaceuticals, Inc. | Triazoles à substitution aryle bicycliques et hétéroaryle bicycliques utiles en tant qu'inhibiteurs axl |
ME01832B (me) | 2006-12-29 | 2014-12-20 | Rigel Pharmaceuticals Inc | Policiklični heteroaril supstituisani triazoli koji su korisni kao axl inhibitori |
EP2114955B1 (fr) | 2006-12-29 | 2013-02-13 | Rigel Pharmaceuticals, Inc. | Triazoles substitués par aryle bicyclique ponté et hétéroaryle bicyclique ponté utilisés comme inhibiteurs d'axl |
JP5567837B2 (ja) * | 2006-12-29 | 2014-08-06 | ライジェル ファーマシューティカルズ, インコーポレイテッド | Axlインヒビターとして有用なN3−ヘテロアリール置換トリアゾールおよびN5−ヘテロアリール置換トリアゾール |
CN110551105B (zh) | 2006-12-29 | 2022-10-18 | 里格尔制药公司 | 用作axl抑制剂的取代三唑 |
WO2009054864A1 (fr) | 2007-10-26 | 2009-04-30 | Rigel Pharmaceuticals, Inc. | Triazoles substitués par aryle polycyclique et triazoles substitués par hétéroaryle polycyclique utiles comme inhibiteurs d'axl |
WO2010005879A1 (fr) | 2008-07-09 | 2010-01-14 | Rigel Pharmaceuticals, Inc. | Triazoles substitués par hétéroaryle bicycliques pontés utiles comme inhibiteurs de axl |
WO2010005876A2 (fr) | 2008-07-09 | 2010-01-14 | Rigel Pharmaceuticals, Inc. | Triazoles à substitution hétéroaryle polycycliques utiles en tant qu’inhibiteurs d’axl |
ES2528032T3 (es) | 2009-01-16 | 2015-02-03 | Rigel Pharmaceuticals, Inc. | Inhibidores de Axl para su uso en terapia de combinación para prevenir, tratar o manejar cáncer metastásico |
WO2010099217A1 (fr) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine |
US20140010783A1 (en) * | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2352944A (en) * | 1942-07-04 | 1944-07-04 | Gen Electric | Triazole derivatives |
FI850994L (fi) * | 1984-03-16 | 1985-09-17 | Ciba Geigy Ag | Foerfarande foer framstaellning av nya 1,2,4-triazacykloalkadienderivat. |
EP1112070B1 (fr) * | 1998-08-20 | 2004-05-12 | Smithkline Beecham Corporation | Nouveaux composes de triazole substitues |
-
1999
- 1999-08-02 GB GBGB9918180.2A patent/GB9918180D0/en not_active Ceased
-
2000
- 2000-07-31 JP JP2001514309A patent/JP2003506362A/ja active Pending
- 2000-07-31 AU AU69898/00A patent/AU6989800A/en not_active Abandoned
- 2000-07-31 EP EP00958343A patent/EP1200415A1/fr not_active Withdrawn
- 2000-07-31 WO PCT/EP2000/007423 patent/WO2001009106A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1200415A1 (fr) | 2002-05-02 |
AU6989800A (en) | 2001-02-19 |
WO2001009106A1 (fr) | 2001-02-08 |
JP2003506362A (ja) | 2003-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9921146D0 (en) | Novel composition | |
GB9918180D0 (en) | Novel compositions | |
GB9921147D0 (en) | Novel composition | |
GB9921037D0 (en) | Compositions | |
GB9904049D0 (en) | Rapidly-soluble compositions | |
GB9902520D0 (en) | Composition | |
AP2001002273A0 (en) | Rescorcinol composition | |
GB2366984B (en) | Composition | |
GB9920148D0 (en) | Novel composition | |
GB9914446D0 (en) | Composition | |
GB9929622D0 (en) | Compositions | |
GB9904931D0 (en) | Compositions | |
GB9903924D0 (en) | Cosmectic compositions | |
GB9926833D0 (en) | Compositions | |
GB2357714B (en) | Composition | |
GB0029455D0 (en) | Novel compositions | |
GB9914582D0 (en) | Composition | |
GB9912420D0 (en) | Compositions | |
GB9912422D0 (en) | Compositions | |
GB9905571D0 (en) | Compositions | |
GB9905572D0 (en) | Compositions | |
GB9904057D0 (en) | Compositions | |
GB9904430D0 (en) | Compositions | |
GB9904599D0 (en) | Compositions | |
GB9912423D0 (en) | Compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |